Sign In
Buy SNY
$43.98
-0.680 (-1.52%)
At Close: Jul 20, 2026
Vulvodynia Treatment Drugs Market Expansion Projected to Gain an Uptick During 2021-2027 Covid-19 Analysis | Pfizer, Sanofi Aventis
05:16pm, Tuesday, 14'th Dec 2021 OpenPR
Another exploration Titled "Worldwide Vulvodynia Treatment Drugs 2019-Market Research Report" gives the Professional and inside and out assessment of extent of momentum and future market and survey of Product Specification, showcase pattern , item type and creation investigation considering central
Data from two Phase 3 studies demonstrating fitusiran significantly reduced bleeds in people with hemophilia A or B, with or without inhibitors, were featured at ASH''s plenary and late-breaking ses
Egypt signs MoU with Sanofi to support Go Green Initiative
01:12pm, Tuesday, 14'th Dec 2021 Egypt Independent
Egypt signed a memorandum of understanding for joint cooperation between the Environmental Affairs Agency, represented in the signature by Ali Abu Senna, CEO of the Environmental Affairs Agency, and Sanofi Egypt, which specializes in the pharmaceutical industry, represented by Sherif Omar, Director General of Sanofi Consumer Healthcare in Egypt and Sudan. The agreement aims to … The post Egypt signs MoU with Sanofi to support Go Green Initiative appeared first on Egypt Independent .
Sanofi Reveals Late-Stage Data For Fitusiran In Hemophilia Patients
12:48pm, Tuesday, 14'th Dec 2021
Sanofi SA (NASDAQ: SNY) presented data from two Phase 3 studies of fitusiran for the prophylactic treatment with hemophilia A or B, with or without inhibitors. Data were shared at the American Soci
Does PFE, ARNA Deal Signal Robust Pharma M&A Activity in 2022?
10:44am, Tuesday, 14'th Dec 2021
The Pfizer (PFE)-Arena (ARNA) deal raises hopes that M&A activity will pick up significantly in 2022. as big drugmakers are sitting on huge piles of cash.
Women''S Health Market is a completely ready-to-refer market research presentation that offers vital information, such as market share, market size, CAGR, and the directly impacting factors. The updated research report presents actionable insights to the market vendors involved and other
New Jersey, United States,- Verified Market Research has recently published a research report titled, “Dementia Drugs Market Size, and Forecast 2021-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application”. Primary and secondary research methodologies have been used to formulate
The Hydroxychloroquine Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate
Covid-19 Impact on Asthma Treatment Drugs Market is Likely to Experience a Tremendous Growth by 2027 | GlaxoSmithKline, Sanofi
04:52pm, Monday, 13'th Dec 2021 OpenPR
Another exploration Titled "Worldwide Asthma Treatment Drugs 2019-Market Research Report" gives the Professional and inside and out assessment of extent of momentum and future market and survey of Product Specification, showcase pattern , item type and creation investigation considering central
Sanofi (SNY) Multiple Myeloma Phase III Study Meets Goal
01:50pm, Monday, 13'th Dec 2021
Sanofi's (SNY) phase III study on Sarclisa is the first to meet the primary endpoint of MRD negativity in transplant-eligible patients with newly diagnosed multiple myeloma.
DUBLIN--(BUSINESS WIRE)--The "Multiple Sclerosis Drugs Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com''s offering. The global multiple sclerosis drugs market is expected to grow from $21.27 billion in 2020 to $22.04 billion in 2021 at a compound annual growth rate (CAGR) of 3.6%. The market is expected to reach $25.95 billion in 2025 at a CAGR of 4%. Major players in the multiple sclerosis drugs market are Biogen, Novartis, Roche, B
Animal Vaccines Market: Future Forecast Assessed on the Basis of How the Key Players Decided to Invest: Merck, Zoetis, Ceva Sant Animale, Sanofi
01:41pm, Monday, 13'th Dec 2021 OpenPR
The latest release from WMR titled Animal Vaccines Market Research Report 2021-2027 (by Product Type, End-User / Application, and Regions / Countries) provides an in-depth assessment of the Animal Vaccines including key market trends, upcoming technologies, industry drivers, challenges, regulatory
Hydroxychloroquine Market Growth in Future Scope 2021-2028 | Sanofi S.A., Amneal Pharmaceuticals, Inc., Laurus Labs Limited
01:17pm, Monday, 13'th Dec 2021 OpenPR
The Hydroxychloroquine Market report focus on the current trends of the market along with detailed analysis which provides data regarding this market rate, and it also predicts the future market growth rate. The Hydroxychloroquine Market study includes research on the
Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients
12:12pm, Monday, 13'th Dec 2021
Sanofi SA (NASDAQ: SNY) and Johnson & Johnson (NYSE: JNJ) posted new data from their myeloma therapies, Sarclisa and Darzalex, respectively. Data were shared at the American Society of Hematology (
New Jersey, United States,- Verified Market Research has recently published a research report titled, Phosphate Binders Market Size, and Forecast 2021-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application. Primary and secondary research methodologies have been used to formulate
